Anti-copper therapies in Alzheimer's disease: new concepts.

Abstract

Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disorder. The recent Metal Hypothesis states that the interaction of Amyloid beta (Abeta, the main constituent of senile plaques) with transition metals is at the basis of AD neurodegeneration. This hypothesis is based on in vitro studies demonstrating that metals (copper, zinc… (More)

Topics

Cite this paper

@article{Squitti2009AnticopperTI, title={Anti-copper therapies in Alzheimer's disease: new concepts.}, author={Rosanna Squitti and Giancarlo Zito}, journal={Recent patents on CNS drug discovery}, year={2009}, volume={4 3}, pages={209-19} }